Mistakes in managing hepatocellular carcinoma and how to avoid them: a narrative review.

Autor:	Niriella MA; Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka., Dassanayake U; Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka., de Silva HJ; Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Jazyk:	angličtina
Zdroj:	Expert review of gastroenterology & hepatology [Expert Rev Gastroenterol Hepatol] 2023 Jul-Dec; Vol. 17 (9), pp. 913-919. Date of Electronic Publication: 2023 Sep 07.
DOI:	10.1080/17474124.2023.2255515
Abstrakt:	Introduction: Hepatocellular carcinoma (HCC) is the most common liver-related cancer and the third leading cause of worldwide cancer-related mortality. Areas Covered: There have been many updated guidelines on the management of HCC in the past few years. Given the increasing burden of HCC in clinical practice, knowledge of evidence-based standards of care for these patients is essential for any practitioner managing patients with HCC. Early detection and judicious treatment based on the stage of the HCC can improve patient outcomes. We performed a PubMed (MEDLINE database) search for the latest guidelines related to the screening, detection, diagnosis, staging, and management of HCC. We aim to highlight some major considerations and common mistakes in managing HCC and attempt to provide evidence-based recommendations. Expert Opinion: The field of HCC management is expected to evolve in the coming years. Increased emphasis on personalized treatment and precision medicine with earlier detection methods, the development of noninvasive diagnostic tools, increased focus on combination therapies and a shift toward more targeted treatments will become more critical.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu